Further mechanistic studies with BP nanoparticles revealed the activation of Toll-like receptor 3 (TLR3)-mediated innate-to-adaptive immune signaling as the mechanism of tumor growth and metastasis inhibition in multiple mouse breast cancer models, with no discernible toxicity observed in the mice (Korangath et al., 2024). This evidence concerns the gene TLR3 and breast cancer.